What is NewLeaf Symbiotics?
NewLeaf Symbiotics is a specialized agricultural technology firm headquartered at the Donald Danforth Plant Science Center in St. Louis, Missouri. The company focuses on the discovery, development, and commercialization of beneficial plant microbes, known as M-trophs. These biological products are engineered to enhance crop yields by strengthening plant health and optimizing nutrient uptake. By integrating these microbial solutions into modern farming, NewLeaf Symbiotics addresses the urgent need for sustainable agricultural practices that improve productivity while minimizing environmental impact. Its market position is defined by a commitment to scientific rigor and a scalable business model that bridges the gap between laboratory research and field-ready agricultural applications.
How much funding has NewLeaf Symbiotics raised?
NewLeaf Symbiotics has raised a total of $116.9M across 7 funding rounds:
Series A
$7M
Series B
$17M
Debt
$3.6M
Series C
$24M
Debt
$350K
Series D
$20M
Series D
$45M
Series A (2013): $7M with participation from Open Prairie Ventures, Pangaea Ventures, and Rockport Capital
Series B (2014): $17M led by RockPort Capital Partners, Pangaea Ventures, Open Prairie Ventures, and Otter Capital
Debt (2017): $3.6M, investors not publicly disclosed
Series C (2017): $24M featuring Otter Capital, Open Praire Ventures, Yard Ventures, Pangaea Ventures, Lewis & Clark Venture Capital, Rockport Capital, and S2G Ventures
Debt (2020): $350K backed by PPP
Series D (2020): $20M with participation from Leaps by Bayer, SABIC Ventures US Holdings, Koch Agronomic Holdings, Otter Capital, S2G Ventures, and RockPort Capital Partners
Series D (2023): $45M led by S2G Ventures and Gullspång Re:food
Key Investors in NewLeaf Symbiotics
S2G Ventures
S2G Ventures is a multi-stage food and agriculture venture fund that invests in entrepreneurs meeting the shifting demands for healthy and sustainable food systems.
Gullspång Re:food
Re:food is a transatlantic growth equity investor focused on supporting visionary food companies that address global challenges in the food system through sustainable change.
Otter Capital
Otter Capital is a private equity firm with a strong track record in developing leading-edge agriculture and food production companies through strategic capital deployment.
What's next for NewLeaf Symbiotics?
With the infusion of $45M, NewLeaf Symbiotics is well-positioned to accelerate its product development pipeline and broaden its market penetration. The strategic focus will likely shift toward scaling production capabilities and deepening partnerships across the agricultural supply chain. As the company transitions into a more mature phase of its lifecycle, the emphasis will remain on demonstrating the long-term efficacy of its microbial products to farmers and industrial stakeholders. By maintaining its focus on sustainable yield enhancement, NewLeaf Symbiotics is poised to capitalize on the growing global demand for climate-resilient and resource-efficient agricultural technologies, ensuring its continued relevance in an evolving food system.
See full NewLeaf Symbiotics company page
